ATE302025T1 - Vorrichtungen zur behandlung und diagnose des restless leg syndroms - Google Patents
Vorrichtungen zur behandlung und diagnose des restless leg syndromsInfo
- Publication number
- ATE302025T1 ATE302025T1 AT99957453T AT99957453T ATE302025T1 AT E302025 T1 ATE302025 T1 AT E302025T1 AT 99957453 T AT99957453 T AT 99957453T AT 99957453 T AT99957453 T AT 99957453T AT E302025 T1 ATE302025 T1 AT E302025T1
- Authority
- AT
- Austria
- Prior art keywords
- cei
- sleep
- agonist
- diagnosis
- treatment
- Prior art date
Links
- 208000005793 Restless legs syndrome Diseases 0.000 title abstract 3
- 238000003745 diagnosis Methods 0.000 title 1
- KPYSYYIEGFHWSV-UHFFFAOYSA-N Baclofen Chemical compound OC(=O)CC(CN)C1=CC=C(Cl)C=C1 KPYSYYIEGFHWSV-UHFFFAOYSA-N 0.000 abstract 2
- GJSURZIOUXUGAL-UHFFFAOYSA-N Clonidine Chemical compound ClC1=CC=CC(Cl)=C1NC1=NCCN1 GJSURZIOUXUGAL-UHFFFAOYSA-N 0.000 abstract 2
- 229960000794 baclofen Drugs 0.000 abstract 2
- FFGPTBGBLSHEPO-UHFFFAOYSA-N carbamazepine Chemical compound C1=CC2=CC=CC=C2N(C(=O)N)C2=CC=CC=C21 FFGPTBGBLSHEPO-UHFFFAOYSA-N 0.000 abstract 2
- 229960000623 carbamazepine Drugs 0.000 abstract 2
- 229960002896 clonidine Drugs 0.000 abstract 2
- 229940052760 dopamine agonists Drugs 0.000 abstract 2
- 239000003136 dopamine receptor stimulating agent Substances 0.000 abstract 2
- 239000003326 hypnotic agent Substances 0.000 abstract 2
- 239000003402 opiate agonist Substances 0.000 abstract 2
- 229940122601 Esterase inhibitor Drugs 0.000 abstract 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 abstract 1
- 229960001231 choline Drugs 0.000 abstract 1
- 239000002329 esterase inhibitor Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000000737 periodic effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Advance Control (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9803760A SE9803760D0 (sv) | 1998-11-04 | 1998-11-04 | Sätt att behandla och diagnostisera syndromet restless legs och motsvarande medel |
| PCT/SE1999/001979 WO2000025821A1 (en) | 1998-11-04 | 1999-11-03 | Method of treating and diagnosing restless legs syndrome and corresponding means |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE302025T1 true ATE302025T1 (de) | 2005-09-15 |
Family
ID=20413169
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99957453T ATE302025T1 (de) | 1998-11-04 | 1999-11-03 | Vorrichtungen zur behandlung und diagnose des restless leg syndroms |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1154795B1 (de) |
| AT (1) | ATE302025T1 (de) |
| DE (1) | DE69926804T2 (de) |
| DK (1) | DK1154795T3 (de) |
| ES (1) | ES2251242T3 (de) |
| SE (1) | SE9803760D0 (de) |
| WO (1) | WO2000025821A1 (de) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6375957B1 (en) | 1997-12-22 | 2002-04-23 | Euro-Celtique, S.A. | Opioid agonist/opioid antagonist/acetaminophen combinations |
| JP2001526228A (ja) | 1997-12-22 | 2001-12-18 | ユーロ−セルティーク，エス．エイ． | オピオイド作動薬／拮抗薬の併用 |
| DE19938823A1 (de) * | 1999-08-19 | 2001-02-22 | Boehringer Ingelheim Pharma | Medikamentöse Behandlung des Restless Leg Syndroms |
| US8338442B2 (en) | 2001-03-30 | 2012-12-25 | Toray Industries, Inc. | Remedies for psychoneurosis |
| CN1525851A (zh) | 2001-05-11 | 2004-09-01 | ������ҩ������˾ | 抗滥用阿片样物质控释剂型 |
| EP1492505B1 (de) | 2002-04-05 | 2015-06-03 | Euro-Celtique S.A. | Pharmazeutische zubereitung enthaltend oxycodon und naloxon |
| US6960571B2 (en) | 2003-03-14 | 2005-11-01 | Luitpold Pharmaceuticals, Inc. | Methods and compositions for administration of iron for the treatment of restless leg syndrome |
| US7297691B2 (en) * | 2003-08-13 | 2007-11-20 | Janssen Pharmaceutica N.V. | Treatment of sleep disorders with cholinesterase inhibitors |
| US7795307B2 (en) | 2003-10-21 | 2010-09-14 | Colucid Pharmaceuticals, Inc. | Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents |
| DK1742624T3 (da) * | 2004-02-18 | 2010-03-08 | Sepracor Inc | Dopamin-agonist-kombinationsterapi med sedativer til forbedring af søvnkvalitet |
| EP1604667A1 (de) * | 2004-06-08 | 2005-12-14 | Euro-Celtique S.A. | Opioide zur Behandlung des Restless Leg Syndroms |
| EP1702558A1 (de) | 2005-02-28 | 2006-09-20 | Euro-Celtique S.A. | Verfahren und Vorrichtung zur Darmtätigkeitserfassung |
| EP1891946A1 (de) * | 2006-08-14 | 2008-02-27 | Santhera Pharmaceuticals (Schweiz) AG | Transmukosale Verabreichung von 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinon |
| JP2010518010A (ja) | 2007-02-02 | 2010-05-27 | コルシド・ファーマシューティカルズ・インコーポレイテッド | コリンエステラーゼを阻害する化合物 |
| AU2008276459A1 (en) * | 2007-07-18 | 2009-01-22 | Colucid Pharmaceuticals, Inc. | Methods for promoting wakefulness |
| MY152279A (en) | 2009-03-10 | 2014-09-15 | Euro Celtique Sa | Immediate release pharmaceutical compositions comprising oxycodone and naloxone |
| EP2251010A1 (de) | 2009-05-08 | 2010-11-17 | Sygnis Bioscience GmbH & Co. KG | Verwendungen von Thiabendazol und Derivaten davon zur Behandlung neurologischer Leiden |
| US20110200671A1 (en) | 2010-02-17 | 2011-08-18 | Sun Pharma Advanced Research Company Ltd. | Method of treating a disease condition susceptible to baclofen therapy |
| US10071089B2 (en) | 2013-07-23 | 2018-09-11 | Euro-Celtique S.A. | Combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPO274596A0 (en) * | 1996-10-04 | 1996-10-31 | Armstrong, Stuart Maxwell | Method for the treatment of neurological or neuropsychiatric disorders |
| DE19701619B4 (de) * | 1997-01-17 | 2007-10-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verwendung von Pramipexol zur Behandlung des restless legs syndroms |
-
1998
- 1998-11-04 SE SE9803760A patent/SE9803760D0/xx unknown
-
1999
- 1999-11-03 DK DK99957453T patent/DK1154795T3/da active
- 1999-11-03 WO PCT/SE1999/001979 patent/WO2000025821A1/en not_active Ceased
- 1999-11-03 DE DE69926804T patent/DE69926804T2/de not_active Expired - Fee Related
- 1999-11-03 AT AT99957453T patent/ATE302025T1/de not_active IP Right Cessation
- 1999-11-03 EP EP99957453A patent/EP1154795B1/de not_active Expired - Lifetime
- 1999-11-03 ES ES99957453T patent/ES2251242T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| SE9803760D0 (sv) | 1998-11-04 |
| WO2000025821A1 (en) | 2000-05-11 |
| ES2251242T3 (es) | 2006-04-16 |
| DE69926804T2 (de) | 2006-06-22 |
| DK1154795T3 (da) | 2006-01-02 |
| EP1154795B1 (de) | 2005-08-17 |
| DE69926804D1 (de) | 2005-09-22 |
| EP1154795A1 (de) | 2001-11-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69926804D1 (de) | Vorrichtungen zur behandlung und diagnose des restless leg syndroms | |
| DE69400799D1 (de) | Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen | |
| DK0668863T3 (da) | Quinuclidinderivat som substans P-antagonist | |
| BR0108977A (pt) | Compostos azacìclicos para uso no tratamento de doenças relaciondas com serotonina | |
| DE60101201D1 (de) | Verwendung von nikotinergen acetylcholinrezeptor-agonisten zur herstellung eines medikaments zur behandlung von keratoconjuctivitis sicca | |
| ATE431141T1 (de) | Zusammensetzungen und verfahren zur behandlung der parkinson-krankheit | |
| CY1107452T1 (el) | Διαδερμικη μορφη χορηγησης για τη θεραπεια του συνδρομου ανησυχων ποδιων | |
| PT1326613E (pt) | Utilizacao de derivados de imidazo[1,2-a]piridin-,imidazo[1,2-a]pirimidin- e imidazo[1,2-a]pirazin-3-il-amina substituidos para a fabricacao de medicamentos para inibicao de nos | |
| ATE375341T1 (de) | Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen | |
| ES2166111T3 (es) | Uso de tiagabina para el tratamiento de trastornos del sueño. | |
| BR0111980A (pt) | Amina substituìda, composto protegido, métodos para tratar um paciente que tenha ou para prevenir que um paciente contraia uma doença ou condição, para inibir a atividade da beta-secretase, para inibir a clivagem da proteìna precursora de amilóide (app), para inibir a produção do peptìdeo beta amilóide (a beta) em uma célula, para inibir a produção de placa beta0amilóide em um animal, e para tratar ou prevenir uma doença compreendendo depósitos de beta-amilóide no cérebro, composição método para produzir um complexo de beta-secretase, conjunto, e, uso de amina substituìda | |
| BR0211119A (pt) | Composto, método de tratar um paciente que tenha, ou de prevenir um paciente de pegar, uma doença ou condição, uso de um composto, e, método para fabricar um composto | |
| HUP0202570A1 (hu) | Izoflavonokat és analogonjait tartalmazó készítmények és terápiás alkalmazásuk | |
| ATE359068T1 (de) | Methode zur behandlung der symptome hormoneller veränderungen, einschliesslich hitzewallungen | |
| SE0002754D0 (sv) | New pharmaceutical combination formulation and method of treatment with the combination | |
| ATE412646T1 (de) | Zur behandlung von schmerzen geeignete therapeutische mittel | |
| UA35567C2 (uk) | Фармацевтичний препарат для лікування хворих з порушеннями функції коагуляції, спосіб лікування таких хворих, спосіб одержання фармацевтичного препарату | |
| ATE469907T1 (de) | Triptolid-analoga zur behandlung von autoimmunkranheiten und entzündungen | |
| DE69725879D1 (de) | VERWENDUNG VON p-AMINOPHENOLDERIVATEN ZUR HERSTELLUNG VON PHARMAZEUTISCHEN ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON NEURODEGENERATIVEN ERKRANKUNGEN | |
| DE60220385D1 (de) | Benzimidazole zur behandlung sexueller fehlfunktionen | |
| DE602005024571D1 (de) | Opioide zur behandlung von ruhelosigkeit in den unteren gliedmassen | |
| ATE271861T1 (de) | Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen | |
| ATE253904T1 (de) | Verwendung von pharmazeutische zusammensetzungen enthaltend thymol und/oder carvacrol in der behandlung von histomoniasis | |
| SE0004101D0 (sv) | New use | |
| DE69822810D1 (de) | Somatostatin und somatostatin agoniste zur behandlung der insulinsunempfindlichkeit und syndrome x |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEIH | Change in the person of patent owner | ||
| UEP | Publication of translation of european patent specification |
Ref document number: 1154795 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |